Grant's analysis, published in the July issue of the Journal of the International Neuropsychological Society, comes as many states consider laws allowing marijuana to be used to treat certain medical conditions. Earlier this year, Maryland became the 10th state to allow marijuana use to relieve pain and other symptoms of AIDS, multiple sclerosis, cancer, glaucoma, and other conditions -- joining Alaska, Arizona, California, Colorado, Hawaii, Maine, Nevada, Oregon, and Washington.
Medicinal marijuana is available by prescription in the Netherlands and a new marijuana drug is expected to be released in Great Britain later this year. In the U.S. and elsewhere, Marinol, a drug that is a synthetic form of marijuana and contains its active ingredient, THC, is available by prescription to treat loss of appetite associated with weight loss in AIDS patients.
Grant says he did the analysis to help determine long-term toxicity from long-term and frequent marijuana use. His center is currently conducting 11 studies to determine its safety and efficacy in treating several diseases.
"This finding enables us to see a marginal level of safety, if those studies prove that cannabis can be effective," Grant tells WebMD. "If we barely find this effect in long-term heavy users, then we are unlikely to see deleterious side effects in individuals who receive cannabis for a short time in a medical setting, which would be safer than what is practiced by street users."
Grant's findings come as no surprise to Tod Mikuriya, MD, former director of non-classified marijuana research for the National Institute of Mental Health Center for Narcotics and Drug Abuse Studies and author of The Marijuana Medical Handbook: A Guide to Therapeutic Use. He is currently president of the California Cannabis Medical Group, which has treated some 20,000 patients with medicinal marijuana and Marinol.
No comments:
Post a Comment